{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:55:13Z","timestamp":1790564113205,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Depression in dementia with Lewy bodies (DLB) is a common neuropsychiatric symptom associated with reduced quality in life. Structural, functional and neurochemical abnormalities in glutamatergic and GABAergic neurotransmission are implicated in the pathophysiology of depression, showing changes in regions involved in emotional processing, including the subgenual cingulate cortex (sgACC), which shows pathological changes in DLB. Using post-mortem tissue from DLB patients and controls, we assessed synaptic and neurochemical changes within the sgACC in relation to depression in DLB. We identified a reduction of layer V GABAergic neurones in depressed DLB cases, potentially indicating reduced inhibition of layer V pyramidal neurons, leading to altered excitation. High-resolution confocal imaging demonstrated a significantly increased volume of presynaptic glutamatergic synapses containing phosphorylated \u03b1-synuclein (s129) in DLB cases, and specifically in depressed DLB cases, potentially as a compensatory response to the accumulation of pathological s129. GABAergic synapses containing s129 were enlarged in both DLB groups showing no depression specific changes. Selective reductions in glutamatergic and GABAergic receptors were seen in depressed DLB cases, suggesting a role in the pathophysiology of depression in DLB, that may prove amenable to therapy with fast-acting antidepressants. Interactions with serotonergic and dopaminergic innervation were observed, where preserved 5HT3B receptor and calbindin characterised non-depressed DLB patients. In depressed DLB cases, this may lead to reduced inhibition of lower layer pyramidal neurones due to reduced dopaminergic coupling and enhanced excitatory activity within the cingulate. Overall, our findings suggest altered excitatory and inhibitory neurotransmission may contribute to the development of depression in DLB.<\/jats:p>","DOI":"10.1038\/s41398-026-04224-x","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:56:08Z","timestamp":1783090568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imbalance in excitation and inhibition in sgACC is associated with depression in dementia with Lewy bodies"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5923-1811","authenticated-orcid":false,"given":"Lina","family":"Gliaudelyt\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Rushton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"4224_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0072-9752(07)84060-7","volume":"84","author":"I McKeith","year":"2007","unstructured":"McKeith I. Dementia with Lewy bodies. Handb Clin Neurol. 2007;84:531\u201348.","journal-title":"Handb Clin Neurol"},{"key":"4224_CR2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/alz.12291","volume":"17","author":"KE McAleese","year":"2021","unstructured":"McAleese KE, Colloby SJ, Thomas AJ, Al-Sarraj S, Ansorge O, Neal J, et al. Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia. Alzheimers Dement. 2021;17:1121\u201333.","journal-title":"Alzheimers Dement"},{"key":"4224_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology"},{"key":"4224_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1479-8301.2011.00368.x","volume":"11","author":"Y Yamane","year":"2011","unstructured":"Yamane Y, Sakai K, Maeda K. Dementia with Lewy Bodies is associated with higher scores on the Geriatric Depression Scale than is Alzheimer\u2019s disease. Psychogeriatrics. 2011;11:157\u201365.","journal-title":"Psychogeriatrics"},{"key":"4224_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1212\/WNL.0b013e3182a2cbd1","volume":"81","author":"BP Boot","year":"2013","unstructured":"Boot BP, Orr CF, Ahlskog JE, Ferman TJ, Roberts R, Pankratz VS, et al. Risk factors for dementia with Lewy bodies A case-control study. Neurology. 2013;81:833\u201340.","journal-title":"Neurology"},{"key":"4224_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/(SICI)1099-1166(199807)13:7<459::AID-GPS796>3.0.CO;2-W","volume":"13","author":"K Ritchie","year":"1998","unstructured":"Ritchie K, Touchon J, Ledesert B. Progressive disability in senile dementia is accelerated in the presence of depression. Int J Geriatr Psych. 1998;13:459\u201361.","journal-title":"Int J Geriatr Psych"},{"key":"4224_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/bpa.12697","volume":"29","author":"L Patterson","year":"2019","unstructured":"Patterson L, Rushton SP, Attems J, Thomas AJ, Morris CM. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders. Brain Pathol. 2019;29:544\u201357.","journal-title":"Brain Pathol"},{"key":"4224_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03298-3","volume":"15","author":"L Gliaudelyte","year":"2025","unstructured":"Gliaudelyte L, Rushton SP, Berlinguer-Palmini R, Thomas AJ, Morris CM. Dopaminergic changes in the subgenual cingulate cortex in dementia with lewy bodies associates with presence of depression. Transl Psychiatry. 2025;15:89.","journal-title":"Transl Psychiatry"},{"key":"4224_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","volume":"62","author":"G Sanacora","year":"2012","unstructured":"Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012;62:63\u201377.","journal-title":"Neuropharmacology"},{"key":"4224_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.tips.2004.11.004","volume":"26","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Kaupmann K. Don\u2019t worry \u2018B\u2019 happy!: a role for GABA(B) receptors in anxiety and depression. Trends Pharmacol Sci. 2005;26:36\u201343.","journal-title":"Trends Pharmacol Sci"},{"key":"4224_CR11","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.euroneuro.2016.03.006","volume":"26","author":"D Downey","year":"2016","unstructured":"Downey D, Dutta A, McKie S, Dawson GR, Dourish CT, Craig K, et al. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate. Eur Neuropsychopharmacol. 2016;26:994\u20131003.","journal-title":"Eur Neuropsychopharmacol"},{"key":"4224_CR12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jamapsychiatry.2022.3384","volume":"79","author":"C Ritter","year":"2022","unstructured":"Ritter C, Buchmann A, Muller ST, Volleberg M, Haynes M, Ghisleni C, et al. Evaluation of prefrontal gamma-aminobutyric acid and glutamate levels in individuals with major depressive disorder using proton magnetic resonance spectroscopy. JAMA Psychiat. 2022;79:1209\u201316.","journal-title":"JAMA Psychiat"},{"key":"4224_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2008.11.021","volume":"117","author":"V Lorenzetti","year":"2009","unstructured":"Lorenzetti V, Allen NB, Fornito A, Yucel M. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord. 2009;117:1\u201317.","journal-title":"J Affect Disord"},{"key":"4224_CR14","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1002\/hbm.20801","volume":"30","author":"PC Koolschijn","year":"2009","unstructured":"Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp. 2009;30:3719\u201335.","journal-title":"Hum Brain Mapp"},{"key":"4224_CR15","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","volume":"30","author":"H Mitani","year":"2006","unstructured":"Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR, Kawahara R. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuro-Psychoph. 2006;30:1155\u20138.","journal-title":"Prog Neuro-Psychoph"},{"key":"4224_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3109\/15622971003611319","volume":"11","author":"L Bocchio-Chiavetto","year":"2010","unstructured":"Bocchio-Chiavetto L, Bagnardi V, Zanardini R, Molteni R, Nielsen MG, Placentino A, et al. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry. 2010;11:763\u201373.","journal-title":"World J Biol Psychiatry"},{"key":"4224_CR17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/S0006-3223(99)00284-X","volume":"47","author":"J Levine","year":"2000","unstructured":"Levine J, Panchalingam K, Rapoport A, Gershon S, McClure RJ, Pettegrew JW. Increased cerebrospinal fluid glutamine levels in depressed patients. Biol Psychiat. 2000;47:586\u201393.","journal-title":"Biol Psychiat"},{"key":"4224_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.biopsych.2006.01.024","volume":"61","author":"MA Frye","year":"2007","unstructured":"Frye MA, Tsai GE, Huggins T, Coyle JT, Post RM. Low cerebrospinal fluid glutamate and glycine in refractory affective disorder. Biol Psychiatry. 2007;61:162\u20136.","journal-title":"Biol Psychiatry"},{"key":"4224_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrn3155","volume":"13","author":"O Marin","year":"2012","unstructured":"Marin O. Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci. 2012;13:107\u201320.","journal-title":"Nat Rev Neurosci"},{"key":"4224_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/sj.mp.4001362","volume":"8","author":"P Brambilla","year":"2003","unstructured":"Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry. 2003;8:721\u201337. 715.","journal-title":"Mol Psychiatry"},{"key":"4224_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/archgenpsychiatry.2011.131","volume":"69","author":"V Gabbay","year":"2012","unstructured":"Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM, et al. Anterior cingulate cortex gamma-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry. 2012;69:139\u201349.","journal-title":"Arch Gen Psychiatry"},{"key":"4224_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.nbd.2011.01.014","volume":"42","author":"A Tripp","year":"2011","unstructured":"Tripp A, Kota RS, Lewis DA, Sibille E. Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis. 2011;42:116\u201324.","journal-title":"Neurobiol Dis"},{"key":"4224_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0165-0327(84)90018-1","volume":"6","author":"F Petty","year":"1984","unstructured":"Petty F, Sherman AD. Plasma GABA levels in psychiatric illness. J Affect Disord. 1984;6:131\u20138.","journal-title":"J Affect Disord"},{"key":"4224_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1176\/ajp.137.3.362","volume":"137","author":"BI Gold","year":"1980","unstructured":"Gold BI, Bowers MB Jr., Roth RH, Sweeney DW. GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry. 1980;137:362\u20134.","journal-title":"Am J Psychiatry"},{"key":"4224_CR25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jad.2012.01.013","volume":"138","author":"J Zhao","year":"2012","unstructured":"Zhao J, Bao AM, Qi XR, Kamphuis W, Luchetti S, Lou JS, et al. Gene expression of GABA and glutamate pathway markers in the prefrontal cortex of non-suicidal elderly depressed patients. J Affect Disord. 2012;138:494\u2013502.","journal-title":"J Affect Disord"},{"key":"4224_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","volume":"33","author":"AM Feyissa","year":"2009","unstructured":"Feyissa AM, Chandran A, Stockmeier CA, Karolewicz B. Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:70\u201375.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4224_CR27","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1017\/S0033291714000841","volume":"44","author":"E Rodriguez-Cano","year":"2014","unstructured":"Rodriguez-Cano E, Sarro S, Monte GC, Maristany T, Salvador R, McKenna PJ, et al. Evidence for structural and functional abnormality in the subgenual anterior cingulate cortex in major depressive disorder. Psychol Med. 2014;44:3263\u201373.","journal-title":"Psychol Med"},{"key":"4224_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-024-07805-2","volume":"633","author":"CJ Lynch","year":"2024","unstructured":"Lynch CJ, Elbau IG, Ng T, Ayaz A, Zhu S, Wolk D, et al. Frontostriatal salience network expansion in individuals in depression. Nature. 2024;633:624\u201333.","journal-title":"Nature"},{"key":"4224_CR29","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1176\/appi.ajp.2012.12020248","volume":"169","author":"A Tripp","year":"2012","unstructured":"Tripp A, Oh H, Guilloux JP, Martinowich K, Lewis DA, Sibille E. Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry. 2012;169:1194\u2013202.","journal-title":"Am J Psychiatry"},{"key":"4224_CR30","doi-asserted-by":"publisher","first-page":"13290","DOI":"10.1073\/pnas.95.22.13290","volume":"95","author":"D Ongur","year":"1998","unstructured":"Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA. 1998;95:13290\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4224_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3233\/JAD-131517","volume":"40","author":"X Zhong","year":"2014","unstructured":"Zhong X, Shi H, Shen Z, Hou L, Luo X, Chen X, et al. 1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer\u2019s disease. J Alzheimers Dis. 2014;40:953\u201366.","journal-title":"J Alzheimers Dis"},{"key":"4224_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.140","volume":"6","author":"L Su","year":"2016","unstructured":"Su L, Blamire AM, Watson R, He J, Hayes L, O\u2019Brien JT. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer\u2019s disease and dementia with Lewy bodies. Transl Psychiatry. 2016;6:e877.","journal-title":"Transl Psychiatry"},{"key":"4224_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2024.103641","volume":"43","author":"X Liu","year":"2024","unstructured":"Liu X, Li Y, Mo Y, Chen B, Hou X, Zhu J, et al. GABAergic imbalance in Parkinson\u2019s disease-related depression determined with MEGA-PRESS. Neuroimage Clin. 2024;43:103641.","journal-title":"Neuroimage Clin"},{"key":"4224_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0006-3223(88)90038-8","volume":"23","author":"GS Alexopoulos","year":"1988","unstructured":"Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiat. 1988;23:271\u201384.","journal-title":"Biol Psychiat"},{"key":"4224_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/08039480600937066","volume":"60","author":"A Korner","year":"2006","unstructured":"Korner A, Lauritzen L, Abelskov K, Gulmann N, Brodersen AM, Wedervang-Jensen T, et al. The geriatric depression scale and the Cornell Scale for Depression in Dementia. A validity study. Nord J Psychiat. 2006;60:360\u20134.","journal-title":"Nord J Psychiat"},{"key":"4224_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, et al. Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol. 2015;129:729\u201348.","journal-title":"Acta Neuropathol"},{"key":"4224_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/jnen\/nlz047","volume":"78","author":"L Patterson","year":"2019","unstructured":"Patterson L, Firbank MJ, Colloby SJ, Attems J, Thomas AJ, Morris CM. Neuropathological changes in dementia with lewy bodies and the cingulate island sign. J Neuropathol Exp Neurol. 2019;78:717\u201324.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4224_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41531-018-0044-6","volume":"4","author":"AK Reeve","year":"2018","unstructured":"Reeve AK, Grady JP, Cosgrave EM, Bennison E, Chen C, Hepplewhite PD, et al. Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2018;4:9.","journal-title":"NPJ Parkinsons Dis"},{"key":"4224_CR39","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.neuint.2005.12.029","volume":"48","author":"JD Erickson","year":"2006","unstructured":"Erickson JD, De Gois S, Varoqui H, Schafer MKH, Weihe E. Activity-dependent regulation of vesicular glutamate and GABA transporters: A means to scale quantal size. Neurochem Int. 2006;48:643\u20139.","journal-title":"Neurochem Int"},{"key":"4224_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1460-9568.2006.05259.x","volume":"25","author":"RM Tordera","year":"2007","unstructured":"Tordera RM, Totterdell S, Wojcik SM, Brose N, Elizalde N, Lasheras B, et al. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur J Neurosci. 2007;25:281\u201390.","journal-title":"Eur J Neurosci"},{"key":"4224_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.neuropharm.2009.09.005","volume":"58","author":"M Zink","year":"2010","unstructured":"Zink M, Vollmayr B, Gebicke-Haerter PJ, Henn FA. Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression. Neuropharmacology. 2010;58:465\u201373.","journal-title":"Neuropharmacology"},{"key":"4224_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2012.09.032","volume":"530","author":"J Gilabert-Juan","year":"2012","unstructured":"Gilabert-Juan J, Varea E, Guirado R, Blasco-Ibanez JM, Crespo C, Nacher J. Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients. Neurosci Lett. 2012;530:97\u2013102.","journal-title":"Neurosci Lett"},{"key":"4224_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19154-y","volume":"8","author":"O Poirel","year":"2018","unstructured":"Poirel O, Mella S, Videau C, Ramet L, Davoli MA, Herzog E, et al. Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer\u2019s disease at various cognitive stages. Sci Rep. 2018;8:938.","journal-title":"Sci Rep"},{"key":"4224_CR44","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2006.03935.x","volume":"98","author":"SL Kirvell","year":"2006","unstructured":"Kirvell SL, Esiri M, Francis PT. Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer\u2019s disease. J Neurochem. 2006;98:939\u201350.","journal-title":"J Neurochem"},{"key":"4224_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1034\/j.1399-5618.2003.00024.x","volume":"5","author":"E Scarr","year":"2003","unstructured":"Scarr E, Pavey G, Sundram S, MacKinnon A, Dean B. Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord. 2003;5:257\u201364.","journal-title":"Bipolar Disord"},{"key":"4224_CR46","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1046\/j.1460-9568.2003.02667.x","volume":"17","author":"JF Cryan","year":"2003","unstructured":"Cryan JF, Kelly PH, Neijt HC, Sansig G, Flor PJ, van Der Putten H. Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur J Neurosci. 2003;17:2409\u201317.","journal-title":"Eur J Neurosci"},{"key":"4224_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/FBP.0b013e32830cd839","volume":"19","author":"K Stachowicz","year":"2008","unstructured":"Stachowicz K, Branski P, Klak K, van der Putten H, Cryan JF, Flor PJ, et al. Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission. Behav Pharmacol. 2008;19:597\u2013603.","journal-title":"Behav Pharmacol"},{"key":"4224_CR48","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/gps.4074","volume":"29","author":"T Araki","year":"2014","unstructured":"Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, et al. The effects of combine treatment of memantine and donepezil on Alzheimer\u2019s disease patients and its relationship with cerebral blood flow in the prefrontal area. Int J Geriatr Psychiatry. 2014;29:881\u20139.","journal-title":"Int J Geriatr Psychiatry"},{"key":"4224_CR49","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","volume":"348","author":"B Reisberg","year":"2003","unstructured":"Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ, et al. Memantine in moderate-to-severe Alzheimer\u2019s disease. N Engl J Med. 2003;348:1333\u201341.","journal-title":"N Engl J Med"},{"key":"4224_CR50","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","volume":"9","author":"M Emre","year":"2010","unstructured":"Emre M, Tsolaki M, Bonuccelli U, Destee A, Tolosa E, Kutzelnigg A, et al. Memantine for patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9:969\u201377.","journal-title":"Lancet Neurol"},{"key":"4224_CR51","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","volume":"8","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, et al. Memantine in patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2009;8:613\u20138.","journal-title":"Lancet Neurol"},{"key":"4224_CR52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neubiorev.2007.07.012","volume":"32","author":"P Allen","year":"2008","unstructured":"Allen P, Laroi F, McGuire PK, Aleman A. The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations. Neurosci Biobehav Rev. 2008;32:175\u201391.","journal-title":"Neurosci Biobehav Rev"},{"key":"4224_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fncir.2016.00035","volume":"10","author":"A Naka","year":"2016","unstructured":"Naka A, Adesnik H. Inhibitory circuits in cortical layer 5. Front Neural Circuits. 2016;10:35.","journal-title":"Front Neural Circuits"},{"key":"4224_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0022-510X(02)00006-0","volume":"195","author":"W Marui","year":"2002","unstructured":"Marui W, Iseki E, Nakai T, Miura S, Kato M, Ueda K, et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci. 2002;195:153\u20139.","journal-title":"J Neurol Sci"},{"key":"4224_CR55","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1017\/S1461145709990587","volume":"13","author":"B Karolewicz","year":"2010","unstructured":"Karolewicz B, Maciag D, O\u2019Dwyer G, Stockmeier CA, Feyissa AM, Rajkowska G. Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. Int J Neuropsychoph. 2010;13:411\u201320.","journal-title":"Int J Neuropsychoph"},{"key":"4224_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fncir.2018.00037","volume":"12","author":"BR Ferguson","year":"2018","unstructured":"Ferguson BR, Gao WJ. PV interneurons: critical regulators of E\/I balance for prefrontal cortex-dependent behavior and psychiatric disorders. Front Neural Circuits. 2018;12:37.","journal-title":"Front Neural Circuits"},{"key":"4224_CR57","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/mp.2010.120","volume":"16","author":"B Luscher","year":"2011","unstructured":"Luscher B, Shen Q, Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry. 2011;16:383\u2013406.","journal-title":"Mol Psychiatry"},{"key":"4224_CR58","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/sj.mp.4001969","volume":"12","author":"A Sequeira","year":"2007","unstructured":"Sequeira A, Klempan T, Canetti L, Ffrench-Mullen J, Benkelfat C, Rouleau GA, et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatr. 2007;12:640\u201355.","journal-title":"Mol Psychiatr"},{"key":"4224_CR59","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0163-7258(03)00037-8","volume":"98","author":"JM Fritschy","year":"2003","unstructured":"Fritschy JM, Brunig I. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol Ther. 2003;98:299\u2013323.","journal-title":"Pharmacol Ther"},{"key":"4224_CR60","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1017\/S1461145708008985","volume":"12","author":"B Karolewicz","year":"2009","unstructured":"Karolewicz B, Szebeni K, Gilmore T, Maciag D, Stockmeier CA, Ordway GA. Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression. Int J Neuropsychopharmacol. 2009;12:143\u201353.","journal-title":"Int J Neuropsychopharmacol"},{"key":"4224_CR61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.26479","volume":"31","author":"L Calo","year":"2016","unstructured":"Calo L, Wegrzynowicz M, Santivanez-Perez J, Grazia Spillantini M. Synaptic failure and alpha-synuclein. Mov Disord. 2016;31:169\u201377.","journal-title":"Mov Disord"},{"key":"4224_CR62","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jalz.2016.04.005","volume":"12","author":"E Bereczki","year":"2016","unstructured":"Bereczki E, Francis PT, Howlett D, Pereira JB, Hoglund K, Bogstedt A, et al. Synaptic proteins predict cognitive decline in Alzheimer\u2019s disease and Lewy body dementia. Alzheimers Dement. 2016;12:1149\u201358.","journal-title":"Alzheimers Dement"},{"key":"4224_CR63","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuroscience.2008.01.030","volume":"152","author":"G Muntane","year":"2008","unstructured":"Muntane G, Dalfo E, Martinez A, Ferrer I. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer\u2019s disease, and in Parkinson\u2019s disease and related alpha-synucleinopathies. Neuroscience. 2008;152:913\u201323.","journal-title":"Neuroscience"},{"key":"4224_CR64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker DG, Lue LF, Adler CH, Shill HA, Caviness JN, Sabbagh MN, et al. Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol. 2013;240:190\u2013204.","journal-title":"Exp Neurol"},{"key":"4224_CR65","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/brain\/awq132","volume":"133","author":"P Garcia-Reitbock","year":"2010","unstructured":"Garcia-Reitbock P, Anichtchik O, Bellucci A, Iovino M, Ballini C, Fineberg E, et al. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson\u2019s disease. Brain. 2010;133:2032\u201344.","journal-title":"Brain"},{"key":"4224_CR66","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, et al. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron. 2010;65:66\u201379.","journal-title":"Neuron"},{"key":"4224_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12565-018-0464-8","volume":"94","author":"K Taguchi","year":"2019","unstructured":"Taguchi K, Watanabe Y, Tsujimura A, Tanaka M. Expression of alpha-synuclein is regulated in a neuronal cell type-dependent manner. Anat Sci Int. 2019;94:11\u201322.","journal-title":"Anat Sci Int"},{"key":"4224_CR68","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s004010000270","volume":"101","author":"E Gomez-Tortosa","year":"2001","unstructured":"Gomez-Tortosa E, Sanders JL, Newell K, Hyman BT. Cortical neurons expressing calcium binding proteins are spared in dementia with Lewy bodies. Acta Neuropathol. 2001;101:36\u201342.","journal-title":"Acta Neuropathol"},{"key":"4224_CR69","doi-asserted-by":"publisher","first-page":"e89327","DOI":"10.1371\/journal.pone.0089327","volume":"9","author":"K Taguchi","year":"2014","unstructured":"Taguchi K, Watanabe Y, Tsujimura A, Tatebe H, Miyata S, Tokuda T, et al. Differential expression of alpha-synuclein in hippocampal neurons. PLoS ONE. 2014;9:e89327.","journal-title":"PLoS ONE"},{"key":"4224_CR70","doi-asserted-by":"publisher","first-page":"17186","DOI":"10.1523\/JNEUROSCI.2220-12.2012","volume":"32","author":"Y Nakata","year":"2012","unstructured":"Nakata Y, Yasuda T, Fukaya M, Yamamori S, Itakura M, Nihira T, et al. Accumulation of alpha-synuclein triggered by presynaptic dysfunction. J Neurosci. 2012;32:17186\u201396.","journal-title":"J Neurosci"},{"key":"4224_CR71","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1093\/brain\/awx275","volume":"140","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Munoz L, Querol-Vilaseca M, et al. Synaptic phosphorylated alpha-synuclein in dementia with Lewy bodies. Brain. 2017;140:3204\u201314.","journal-title":"Brain"},{"key":"4224_CR72","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC. alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010;329:1663\u20137.","journal-title":"Science"},{"key":"4224_CR73","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0896-6273(02)00671-2","volume":"34","author":"XD Zhang","year":"2002","unstructured":"Zhang XD, Kim-Miller MJ, Fukuda M, Kowalchyk JA, Martin TFJ. Ca2+-dependent synaptotagmin binding to SNAP-25 is essential for Ca2+-triggered exocytosis. Neuron. 2002;34:599\u2013611.","journal-title":"Neuron"},{"key":"4224_CR74","doi-asserted-by":"publisher","first-page":"10389","DOI":"10.1523\/JNEUROSCI.1040-17.2017","volume":"37","author":"J Houenou","year":"2017","unstructured":"Houenou J, Boisgontier J, Henrion A, d\u2019Albis MA, Dumaine A, Linke J, et al. A multilevel functional study of a SNAP25 at-risk variant for bipolar disorder and schizophrenia. J Neurosci. 2017;37:10389\u201397.","journal-title":"J Neurosci"},{"key":"4224_CR75","doi-asserted-by":"publisher","first-page":"l5572","DOI":"10.1136\/bmj.l5572","volume":"366","author":"S Jauhar","year":"2019","unstructured":"Jauhar S, Morrison P. Esketamine for treatment resistant depression. BMJ. 2019;366:l5572.","journal-title":"BMJ"},{"key":"4224_CR76","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","volume":"28","author":"SH Preskorn","year":"2008","unstructured":"Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J Clin Psychopharmacol. 2008;28:631\u20137.","journal-title":"J Clin Psychopharmacol"},{"key":"4224_CR77","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/JCP.0b013e31825d70d6","volume":"32","author":"L Ibrahim","year":"2012","unstructured":"Ibrahim L, Diaz Granados N, Jolkovsky L, Brutsche N, Luckenbaugh DA, Herring WJ, et al. A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder. J Clin Psychopharmacol. 2012;32:551\u20137.","journal-title":"J Clin Psychopharmacol"},{"key":"4224_CR78","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/7854_2009_30","volume":"2","author":"JR Atack","year":"2010","unstructured":"Atack JR. GABAA receptor alpha2\/alpha3 subtype-selective modulators as potential nonsedating anxiolytics. Curr Top Behav Neurosci. 2010;2:331\u201360.","journal-title":"Curr Top Behav Neurosci"},{"key":"4224_CR79","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bbr.2010.10.009","volume":"217","author":"I Vollenweider","year":"2011","unstructured":"Vollenweider I, Smith KS, Keist R, Rudolph U. Antidepressant-like properties of alpha2-containing GABA(A) receptors. Behav Brain Res. 2011;217:77\u201380.","journal-title":"Behav Brain Res"},{"key":"4224_CR80","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4088\/JCP.09m05131gry","volume":"72","author":"M Fava","year":"2011","unstructured":"Fava M, Schaefer K, Huang H, Wilson A, Iosifescu DV, Mischoulon D, et al. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. J Clin Psychiatry. 2011;72:473\u20139.","journal-title":"J Clin Psychiatry"},{"key":"4224_CR81","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pbb.2018.10.005","volume":"175","author":"Z Xiong","year":"2018","unstructured":"Xiong Z, Zhang K, Ishima T, Ren Q, Chang L, Chen J, et al. Comparison of rapid and long-lasting antidepressant effects of negative modulators of alpha5-containing GABAA receptors and (R)ketamine in a chronic social defeat stress model. Pharmacol Biochem Behav. 2018;175:139\u201345.","journal-title":"Pharmacol Biochem Behav"},{"key":"4224_CR82","doi-asserted-by":"crossref","unstructured":"Zanos P, Nelson ME, Highland JN, Krimmel SR, Georgiou P, Gould TD, et al. A negative allosteric modulator for alpha5 Subunit-Containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice. eNeuro 2017; 4:ENEURO.0285-16.2017.","DOI":"10.1523\/ENEURO.0285-16.2017"},{"key":"4224_CR83","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1023\/A:1022486705184","volume":"23","author":"FE Bloom","year":"1998","unstructured":"Bloom FE, Morales M. The central 5-HT3 receptor in CNS disorders. Neurochem Res. 1998;23:653\u20139.","journal-title":"Neurochem Res"},{"key":"4224_CR84","doi-asserted-by":"publisher","DOI":"10.1126\/science.add7046","volume":"382","author":"K Siletti","year":"2023","unstructured":"Siletti K, Hodge R, Mossi Albiach A, Lee KW, Ding SL, Hu L, et al. Transcriptomic diversity of cell types across the adult human brain. Science. 2023;382:eadd7046.","journal-title":"Science"},{"key":"4224_CR85","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41586-019-1506-7","volume":"573","author":"RD Hodge","year":"2019","unstructured":"Hodge RD, Bakken TE, Miller JA, Smith KA, Barkan ER, Graybuck LT, et al. Conserved cell types with divergent features in human versus mouse cortex. Nature. 2019;573:61\u201368.","journal-title":"Nature"},{"key":"4224_CR86","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1113\/jphysiol.1991.sp018742","volume":"441","author":"N Ropert","year":"1991","unstructured":"Ropert N, Guy N. Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro. J Physiol. 1991;441:121\u201336.","journal-title":"J Physiol"},{"key":"4224_CR87","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0168-0102(94)90163-5","volume":"18","author":"T Maeda","year":"1994","unstructured":"Maeda T, Kaneko S, Satoh M. Inhibitory influence via 5-HT3 receptors on the induction of LTP in mossy fiber-CA3 system of guinea-pig hippocampal slices. Neurosci Res. 1994;18:277\u201382.","journal-title":"Neurosci Res"},{"key":"4224_CR88","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/0269881114543719","volume":"28","author":"E Dale","year":"2014","unstructured":"Dale E, Zhang H, Leiser SC, Xiao Y, Lu D, Yang CR, et al. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. J Psychopharmacol. 2014;28:891\u2013902.","journal-title":"J Psychopharmacol"},{"key":"4224_CR89","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2015.12.012","volume":"103","author":"JA Waller","year":"2016","unstructured":"Waller JA, Chen F, Sanchez C. Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures. Neuropharmacology. 2016;103:143\u201354.","journal-title":"Neuropharmacology"},{"key":"4224_CR90","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2502558122","volume":"122","author":"K Lancon","year":"2025","unstructured":"Lancon K, Tian J, Bach H, Drapeau P, Poulin JF, Seguela P. Synergistic deficits in parvalbumin interneurons and dopamine signaling drive ACC dysfunction in chronic pain. Proc Natl Acad Sci USA. 2025;122:e2502558122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4224_CR91","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1111\/epi.17004","volume":"62","author":"A Brodovskaya","year":"2021","unstructured":"Brodovskaya A, Kapur J. Anticonvulsant dopamine type 2 receptor agonist activates inhibitory parvalbumin interneurons. Epilepsia. 2021;62:e147\u2013e152.","journal-title":"Epilepsia"},{"key":"4224_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03794-6","volume":"16","author":"L Gauthier","year":"2025","unstructured":"Gauthier L, Drui G, Debatisse J, Saga Y, Millot M, Martinez E, et al. Dopamine and serotonin neurotransmissions exert complementary control over primate approach and avoidance. Transl Psychiatry. 2025;16:27.","journal-title":"Transl Psychiatry"},{"key":"4224_CR93","first-page":"660","volume":"27","author":"JP Ramirez-Mahaluf","year":"2017","unstructured":"Ramirez-Mahaluf JP, Roxin A, Mayberg HS, Compte A. A computational model of major depression: the role of glutamate dysfunction on cingulo-frontal network dynamics. Cereb Cortex. 2017;27:660\u201379.","journal-title":"Cereb Cortex"},{"key":"4224_CR94","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1523\/JNEUROSCI.3195-17.2018","volume":"38","author":"J Sellmeijer","year":"2018","unstructured":"Sellmeijer J, Mathis V, Hugel S, Li XH, Song Q, Chen QY, et al. Hyperactivity of anterior cingulate cortex areas 24a\/24b drives chronic pain-induced anxiodepressive-like consequences. J Neurosci. 2018;38:3102\u201315.","journal-title":"J Neurosci"},{"key":"4224_CR95","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.euroneuro.2020.12.006","volume":"43","author":"ES Brown","year":"2021","unstructured":"Brown ES, McArdle M, Palka J, Bice C, Ivleva E, Nakamura A, et al. A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder. Eur Neuropsychopharm. 2021;43:92\u2013101.","journal-title":"Eur Neuropsychopharm"},{"key":"4224_CR96","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/13872877251340084","volume":"106","author":"E Cumbo","year":"2025","unstructured":"Cumbo E, Migliore D. Differential effects of antidepressants on cognition in Alzheimer\u2019s disease with depression: A sub-group analysis of an open-label, observational study. J Alzheimers Dis. 2025;106:271\u20139.","journal-title":"J Alzheimers Dis"},{"key":"4224_CR97","first-page":"1043","volume":"13","author":"A Tundo","year":"2023","unstructured":"Tundo A, Betro S, de Filippis R, Marchetti F, Nacca D, Necci R, et al. Pramipexole augmentation for treatment-resistant unipolar and bipolar depression in the real world: a systematic review and meta-analysis. Life (Basel). 2023;13:1043.","journal-title":"Life (Basel)"},{"key":"4224_CR98","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clinthera.2009.01.012","volume":"31","author":"AF Leentjens","year":"2009","unstructured":"Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ. The effect of pramipexole on mood and motivational symptoms in Parkinson\u2019s disease: a meta-analysis of placebo-controlled studies. Clin Ther. 2009;31:89\u201398.","journal-title":"Clin Ther"},{"key":"4224_CR99","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.biopsych.2006.01.016","volume":"59","author":"M Fava","year":"2006","unstructured":"Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006;59:1052\u201360.","journal-title":"Biol Psychiatry"},{"key":"4224_CR100","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.nicl.2016.10.011","volume":"12","author":"V Onofrj","year":"2016","unstructured":"Onofrj V, Delli Pizzi S, Franciotti R, Taylor JP, Perfetti B, Caulo M, et al. Medio-dorsal thalamus and confabulations: Evidence from a clinical case and combined MRI\/DTI study. Neuroimage Clin. 2016;12:776\u201384.","journal-title":"Neuroimage Clin"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04224-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:02:41Z","timestamp":1790560961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04224-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4224"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04224-x","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR or the UK Department of Health. The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Ethical approval was granted by Newcastle and North Tyneside-1 National Health Service (NHS) Research Ethics Committee (ref: 09\/H0908\/42). An informed consented was obtained from all donors for the use of brain tissue for research purposes. At the time of death next of kin assented to tissue donation.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"493"}}